As far as we know now there are no genetically engineered chickens
In this section of Seattle Organic Restaurants I’m going to talk about genetically modified chickens
Recently I read an article about KFC no longer being able to call themselves “Kentucky Fried Chicken” because they don’t actually use chicken in their products, but instead use genetically engineered chickens that looks like this:
WASHINGTON — A team at the British institute that cloned Dolly the sheep has made a genetically engineered chicken that produces cancer drugs in its eggs.
Genetically Engineered Chickens On fluffy-our pet chicken
Genetically Engineered Chickens Chickens are not real
This is a forwarded email alleging that KFC (formerly known as Kentucky Fried Chicken) is trying to increase profits by developing genetically engineered chickens that have more meat, are cheaper to raise, and faster to process. They are variously described as having no heads, no beaks, no legs, and no feathers. That’s why they changed their name to KFC. When placed in ultraviolet light, the beaks and feet of these genetically engineered chicken glow neon green, to help researchers tell them apart from the other birds. But glow-in-the-dark features aren't the traits these birds are being breed for, but rather the ability to help fight the spread of avian bird flu.KFC denies it and there is no evidence of the genetically engineered chickens described. KFC uses chickens that are born from other chickens in the normal way. KFC did not change it’s name in order to accommodate chickens that are not really chickens.The DT40 cell line has been used extensively to better understand the nature of immunoglobulin diversification in chickens, including the mechanism of GC (–). The cell line has also been used to develop chicken antibodies to novel targets using in vitro selection strategies (, ). We have inserted human V gene arrays into the chicken immunoglobulin loci of DT40. In principle, the human V genes in DT40 cells could be diversified in vitro to provide an unselected library of immunoglobulin sequences from which antigen-specific antibodies could be extracted. However, most therapeutic antibodies are derived from immunized animals producing affinity-matured, antigen-specific antibodies. In the current context, we have used DT40 cells to provide in vitro proof of concept that arrays of human-derived immunoglobulin gene sequences can be diversified by chicken B cells. Subsequently, these sequences will be introduced into chickens to provide genetically engineered animals that can be immunized to produce affinity-matured, antigen-specific antibodies with therapeutic potential. Thus, our purpose with DT40 is to determine whether targeted synthetic human V gene arrays can be used as a substrate for genetic diversification in chicken cells in a way that mirrors what is known regarding the native chicken immunoglobulin loci. Affirmative data in the DT40 culture system inspires confidence that the effort required on the arduous path to generating a genetically engineered chicken will be rewarded with a transgenic animal that performs as expected.